85 related articles for article (PubMed ID: 34894899)
1. Clinical, pathologic, and molecular characterization of a non-metastatic multicentric cutaneous mast cell tumor in a cow.
Chevallier L; Briand A; Reyes-Gomez E; Defer W; Millemann Y; Béguin J
Vet Clin Pathol; 2024 Mar; 53(1):131-135. PubMed ID: 38418393
[TBL] [Abstract][Full Text] [Related]
2. Characterization of WWOX expression and function in canine mast cell tumors and malignant mast cell lines.
Makii R; Cook H; Louke D; Breitbach J; Jennings R; Premanandan C; Green EM; Fenger JM
BMC Vet Res; 2020 Oct; 16(1):415. PubMed ID: 33129329
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Mast Cells in the Pathology of COVID-19: Clinical and Laboratory Parallels.
Budnevsky AV; Avdeev SN; Kosanovic D; Ovsyannikov ES; Savushkina IA; Alekseeva NG; Feigelman SN; Shishkina VV; Filin AA; Esaulenko DI; Perveeva IM
Cells; 2024 Apr; 13(8):. PubMed ID: 38667325
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system.
Bulak K; Kycko A; Śmiech A; Łopuszyński W
J Vet Res; 2023 Dec; 67(4):611-618. PubMed ID: 38130452
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous mastocytosis in 8 young dogs and review of literature.
Yang C; Bradley CW; Preziosi D; Mauldin EA
Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
7. Cyto- and Histopographic Assessment of CPA3-Positive Testicular Mast Cells in Obstructive and Non-Obstructive Azoospermia.
Atiakshin D; Kulchenko N; Kostin A; Ignatyuk M; Protasov A; Klabukov I; Baranovskii D; Faniev M; Korovyakova E; Chekmareva I; Buchwalow I; Tiemann M
Cells; 2024 May; 13(10):. PubMed ID: 38786055
[TBL] [Abstract][Full Text] [Related]
8. Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation.
Krysko O; Bourne JH; Kondakova E; Galova EA; Whitworth K; Newby ML; Bachert C; Hill H; Crispin M; Stamataki Z; Cunningham AF; Pugh M; Khan AO; Rayes J; Vedunova M; Krysko DV; Brill A
Front Immunol; 2022; 13():968981. PubMed ID: 36225927
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages and tumor-infiltrating lymphocytes in canine cutaneous and subcutaneous mast cell tumors.
Bertola L; Pellizzoni B; Giudice C; Grieco V; Ferrari R; Chiti LE; Stefanello D; Manfredi M; De Zani D; Recordati C
Vet Pathol; 2024 Apr; ():3009858241244851. PubMed ID: 38647163
[TBL] [Abstract][Full Text] [Related]
10. What clinicopathological factors predict prognosis for canine subcutaneous mast cell tumours?
Peaston A
Vet Rec; 2023 Jul; 193(1):31-33. PubMed ID: 37417510
[No Abstract] [Full Text] [Related]
11. Evaluation of New Immunohistochemical Approaches for the Study of Kidney Tumors in Geriatric.
Pavlova TV; Pilkevich NB; Bessmertnyi DV; Pavlov IA; Atiakshin DV; Pavlova LA
Arch Razi Inst; 2021 Oct; 76(4):1107-1113. PubMed ID: 35096347
[TBL] [Abstract][Full Text] [Related]
12. The 2-tier grading system identifies canine cutaneous and/or subcutaneous mast cell tumors with aggressive biological behavior regardless of growth model.
Sabattini S; Brocanelli A; Zaccone R; Faroni E; Renzi A; Ciammaichella L; Bettini G; Marconato L
Vet Pathol; 2024 Apr; ():3009858241240443. PubMed ID: 38577816
[TBL] [Abstract][Full Text] [Related]
13. Development of a flow cytometric panel to assess prognostic biomarkers in fine needle aspirates of canine cutaneous or subcutaneous mast cell tumors.
Wu B; Lejeune A; Affolter VK; Iamone G; Riondato F; Kol A
Front Vet Sci; 2023; 10():1279881. PubMed ID: 38076567
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to mitotic index is predictive for survival for canine cutaneous mast cell tumors.
Vet Pathol; 2024 May; ():3009858241252668. PubMed ID: 38695554
[No Abstract] [Full Text] [Related]
15. Diffuse muscular metastasis in a dog with a cutaneous mast cell tumour.
Aledón-Català I; Ziobro P; Frezoulis PS
J Small Anim Pract; 2024 May; ():. PubMed ID: 38730564
[No Abstract] [Full Text] [Related]
16. Diagnostic and prognostic significance of mast cell markers in HIV/AIDS: Current insights and future directions.
Obeagu EI
Medicine (Baltimore); 2024 May; 103(20):e38117. PubMed ID: 38758896
[TBL] [Abstract][Full Text] [Related]
17. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
Hämäläinen S; Kareinen L; Sukura A; Kareinen I
Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
[TBL] [Abstract][Full Text] [Related]
18. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
